Inhibition of Sphingosine-1-Phosphate Receptor 2 Prevents Thoracic Aortic Dissection and Rupture
Background: Numerous pieces of evidence have indicated that thoracic aortic dissection (TAD) is an inflammatory disease. Sphingosine-1-phosphate receptor 2 (S1PR2) signaling is a driver in multiple inflammatory diseases. Here, we examined the S1PR2 expression in TAD lesions and explored the effect o...
Main Authors: | Guangwei Pan, Mengyang Liao, Yong Dai, Yang Li, Xiaole Yan, Wuqian Mai, Jinping Liu, Yuhua Liao, Zhihua Qiu, Zihua Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.748486/full |
Similar Items
-
Targeting IL-1β in the Treatment of Atherosclerosis
by: Wuqian Mai, et al.
Published: (2020-12-01) -
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Promoted Osteogenesis by Increasing Vesicle Trafficking, Wnt/Ca<sup>2+</sup>, and BMP/Smad Signaling
by: Simon Lin, et al.
Published: (2021-11-01) -
Inactivation of sphingosine-1-phosphate receptor 2 (S1PR2) decreases demyelination and enhances remyelination in animal models of multiple sclerosis
by: Maryam S. Seyedsadr, et al.
Published: (2019-04-01) -
JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission
by: Jiaxu Zhou, et al.
Published: (2023-10-01) -
Inhibition of Sphingosine-1-Phosphate Receptor 2 by JTE013 Enhanced Alveolar Bone Regeneration by Promoting Angiogenesis
by: William Lory, et al.
Published: (2023-02-01)